![](/img/cover-not-exists.png)
PDB64 COST-EFFECTIVENESS OF CANAGLIFLOZIN TREATMENT IN CHINESE PATIENTS WITH TYPE 2 DIABETES AND KIDNEY DISEASE
Wu, B.Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.946
Date:
November, 2019
File:
PDF, 381 KB
2019